Progenics Pharmaceuticals Inc (PGNX.OQ)

PGNX.OQ on NASDAQ Stock Exchange Global Select Market

6.77USD
21 Nov 2014
Price Change (% chg)

$0.35 (+5.45%)
Prev Close
$6.42
Open
$6.54
Day's High
$7.03
Day's Low
$6.53
Volume
528,671
Avg. Vol
283,705
52-wk High
$7.45
52-wk Low
$3.15

PGNX.OQ

Chart for PGNX.OQ

About

Progenics Pharmaceuticals, Inc. (Progenics) is a biopharmaceutical company focuses on research and development for biotechnology product candidates in oncology, virology, supportive care and gastroenterology. It is also engaged in research to identify multiplex phosphoinositide 3-kinase inhibitors for blocking signaling pathways... (more)

Overall

Beta: 1.56
Market Cap (Mil.): $446.55
Shares Outstanding (Mil.): 69.56
Dividend: --
Yield (%): --

Financials

  PGNX.OQ Industry Sector
P/E (TTM): 134.96 38.05 39.20
EPS (TTM): 0.05 -- --
ROI: 5.69 17.86 17.16
ROE: 7.22 18.61 18.09
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks